Invention Grant
- Patent Title: Inhibitors of AkT activity
- Patent Title (中): Akt活性抑制剂
-
Application No.: US13774022Application Date: 2013-02-22
-
Publication No.: US08946278B2Publication Date: 2015-02-03
- Inventor: Mark A. Seefeld , Meagan B. Rouse , Dirk A. Heerding , Dennis S. Yamashita , Kenneth C. McNulty
- Applicant: GlaxoSmithKline LLC
- Applicant Address: US DE Wilmington
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US DE Wilmington
- Agent Wayne J. Dustman; Edward R. Gimmi
- Main IPC: A01N43/56
- IPC: A01N43/56 ; A61K31/45 ; C07D231/00 ; C07D403/00 ; C07D403/02 ; C07D487/00 ; C07D409/04 ; A61K31/12 ; C07D403/04 ; C07D405/04 ; C07D405/12 ; C07D409/12 ; C07D409/14
Abstract:
Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
Public/Granted literature
- US20130231378A1 INHIBITORS OF AkT ACTIVITY Public/Granted day:2013-09-05
Information query
IPC分类:
